PRAEFKE, Bent,KLÖVEKORN, Philip,SELIG, Roland,ALBRECHT, Wolfgang,LAUFER, Stefan
申请号：
AU2019216264
公开号：
AU2019216264A1
申请日:
2019.01.30
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The invention relates to pyrazolo-pyridine compounds which inhibit mitogen-activated protein kinase kinase 4 (MKK4) and in particular, selectively inhibit MKK4 over protein kinases JNK1 and MKK7. The compounds are useful for promoting liver regeneration or reducing or preventing hepatocyte death. They are further useful for treating osteoarthritis or rheumatoid arthritis, or CNS-related diseases.
